{Reference Type}: Journal Article
{Title}: Long-term outcome and fertility results of intraplacental choriocarcinoma: a retrospective study of 14 patients and literature review.
{Author}: Liu Y;Song X;Zhang H;Feng F;Zhao J;Yang J;Ren T;Wan X;Jiang F;Li Y;Xiang Y;
{Journal}: Orphanet J Rare Dis
{Volume}: 19
{Issue}: 1
{Year}: 2024 May 22
{Factor}: 4.303
{DOI}: 10.1186/s13023-024-03199-6
{Abstract}: <B>BACKGROUND: </B>Intraplacental choriocarcinoma (IC) is an extremely rare subtype of gestational choriocarcinoma. The long-term follow-up and reproductive outcomes of IC patients remain unclear. Here, we report a series of 14 cases and conduct a literature review to assess the fertility and recurrence results of this rare disease.<BR><B>RESULTS: </B>Fourteen patients with pathologically confirmed IC treated in Peking Union Medical College Hospital between January 2002 and July 2022 were included in this study. Half of them had metastatic IC and were treated by chemotherapy with or without surgery. Only 1 patient had chemoresistant disease, but she achieved complete remission after immunotherapy. The median follow-up time was 45.5 months (range 4-192), and no recurrence occurred. One metastatic IC patient who achieved remission after chemotherapy had a full-term delivery. Among the 5 patients with fertility demands, 3 abandoned their pursuit of pregnancy because of "fear and worry about choriocarcinoma recurrence". We reviewed a total of 89 cases of IC in English and Chinese literature from 1963 to 2022, and only 5 cases with subsequent pregnancy were reported, all of them were nonmetastatic IC cases.<BR><B>CONCLUSIONS: </B>IC is sensitive to chemotherapy and has good long-term remission and a low recurrence rate. Patients with metastatic or nonmetastatic IC can have good pregnancy results after treatment. Doctors should pay more attention to the psychology of these patients.<BR><B>BACKGROUND: </B>N/A.